U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07776405) titled 'A Double-Blinded Study on Rapid and Sustained Pain Relief Topical Cannabidiol for Plantar Fasciitis' on Aug. 17.

Brief Summary: This prospective, double-blinded, placebo-controlled study evaluates the efficacy of a 6000 mg transdermal CBD cream in adults with plantar fasciitis. Fifty participants will apply either CBD or placebo once daily for one month.

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Plantar Fasciitis

Intervention: DRUG: transdermal CBD cream (Tolcylen(R), Marlinz Pharma)

The active product is the study CBD cream supplied by the manufacturer. Dosing is three pumps per application which deliv...